FDA Revokes Hydroxychloroquine Approval

FDA Revokes Hydroxychloroquine Approval

(NewsBreakDaily.org) – Three months ago, the US Food and Drug Administration issued an Emergency Use Authorization saying that hydroxychloroquine (HCQ) and chloroquine (CQ) could only be used in clinical trials and hospitals. This news came as a surprise to many people both in the US and around the world who have taken these anti-malarial drugs and seen good results in the fight against COVID-19. Even President Trump has taken HCQ.

For the past couple of months, he has been a champion for the drug and its potential benefits. Democrats have been rooting against it, but that’s likely only because Trump was for it.

But on Monday, the FDA decided to revoke even the emergency use of the drug that has become a political football.

According to the FDA, they based their revocation of HCQ and CQ on new information. They claim that the drug may not be as effective as once thought in treating the virus. The administration also cautioned it could potentially be dangerous and lead to cardiac-related side effects.

And the FDA isn’t the only organization that has grown sour on HCQ. In May, the World Health Organization (WHO) suspended all of its clinical trials with the same concerns about the risks and effectiveness of the drug.

Because of that and Monday’s FDA ruling, it’s unlikely doctors will continue prescribing it.

Copyright 2020, NewsBreakDaily.org